Pavan Cheruvu

CEO at Sio Gene Therapies

Pavan Cheruvu, MD, has served as Sio’s President and Chief Executive Officer since February 2018. A board-certified physician, Dr. Cheruvu completed his residency in internal medicine at Johns Hopkins Hospital and continued his training as a clinical fellow in cardiovascular medicine at the University of California, San Francisco. Dr. Cheruvu previously worked as a management consultant at McKinsey & Company, where he focused on organizational and R&D strategy while serving a variety of clients, including large- and mid-cap biopharmaceutical firms. Dr. Cheruvu graduated summa cum laude from Duke University, obtained a master’s degree from Oxford University as a Rhodes Scholar, and obtained his medical degree in a joint program between Harvard Medical School and the Massachusetts Institute of Technology. He also serves as a board observer at Arvelle Therapeutics. He currently lives with his wife and daughter in New York City.

Timeline

  • CEO

    Current role

View in org chart